Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
Clinical trial NCT01325181 · COMPLETED
Trial details
- NCT number
- NCT01325181
- Sponsor
- Jang Won Heo
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-09-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.